Todd Wider Sells 74,108 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Todd Wider sold 74,108 shares of the stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $8.76, for a total transaction of $649,186.08. Following the transaction, the director directly owned 710,230 shares in the company, valued at $6,221,614.80. This trade represents a 9.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

ASP Isotopes Price Performance

ASPI stock opened at $9.34 on Friday. The stock has a market capitalization of $858.44 million, a PE ratio of -15.31 and a beta of 3.29. The company’s 50-day moving average is $9.53 and its 200-day moving average is $7.73. The company has a debt-to-equity ratio of 3.53, a current ratio of 14.72 and a quick ratio of 14.56. ASP Isotopes Inc. has a 1 year low of $2.78 and a 1 year high of $11.86.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.92). ASP Isotopes had a negative net margin of 2,181.62% and a negative return on equity of 239.22%. The business had revenue of $1.20 million during the quarter, compared to the consensus estimate of $1.60 million. Equities research analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Investors Weigh In On ASP Isotopes

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. BNP Paribas Financial Markets purchased a new stake in ASP Isotopes in the 4th quarter valued at about $34,000. Ameritas Investment Partners Inc. increased its stake in ASP Isotopes by 41.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock valued at $40,000 after buying an additional 1,600 shares during the last quarter. SBI Securities Co. Ltd. increased its stake in ASP Isotopes by 84.8% in the 1st quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company’s stock valued at $44,000 after buying an additional 4,299 shares during the last quarter. Millennium Management LLC purchased a new stake in ASP Isotopes in the 4th quarter valued at about $55,000. Finally, Fortitude Advisory Group L.L.C. purchased a new stake in shares of ASP Isotopes during the 1st quarter worth approximately $64,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ASPI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Saturday, September 27th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research report on Wednesday, September 17th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $11.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.